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Abstract
Background: Left ventricular pump function requires a complex interplay involving myocardial fibers orientated in
the longitudinal, oblique and circumferential directions. Long axis dysfunction appears to be an early marker for a
number of pathological states. We hypothesized that mitral annular plane systolic excursion (MAPSE) measured
during cine-cardiovascular magnetic resonance (CMR) reflects changes in long axis function and may be an early
marker for adverse cardiovascular outcomes. The aims of this study were therefore: 1) To assess the feasibility and
reproducibility of MAPSE measurements during routine cine-CMR; and 2) To assess whether MAPSE, as a surrogate
for long axis function, is a predictor of major adverse cardiovascular events (MACE).
Methods: Four hundred consecutive patients undergoing CMR were prospectively enrolled. MAPSE was measured
in the 4-chamber cine view. Patients were prospectively followed for major adverse cardiac events (MACE) - death,
non-fatal myocardial infarction, hospitalization for heart failure or unstable angina, and late revascularization. Cox
proportional hazards regression modeling was used to identify factors independently associated with MACE.
Net reclassification improvement (NRI) was calculated to assess whether addition of MAPSE resulted in improved
risk reclassification of MACE.
Results: Seventy-two MACE occurred during a median follow-up of 14.5 months. By Kaplan-Meier analysis, patients
with lateral MAPSE <1.11 cm (median) experienced significantly higher incidence of MACE than patients with a
MAPSE ≥1.11 cm (p = 0.027). After adjustment for established clinical risk factors which were univariate predictors
(age, diabetes, hypertension, NYHA class, LV mass), lateral MAPSE remained a significant independent predictor of
MACE (HR = 4.384 per cm decrease or 1.344 per 2 mm decrease; p = 0.020). Incorporation of lateral MAPSE into this
risk model resulted in a net reclassification improvement (NRI) of 0.18 (p = 0.006).
Conclusions: Reduced long axis function assessed with lateral MAPSE during cine-CMR is an independent predictor
of MACE.
Keywords: Cardiovascular magnetic resonance, Prognosis, Left ventricular function, Longitudinal strain, Mitral
annular plane systolic excursion, Atrioventricular plane displacement (AVPD)
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Background
Left ventricular pump function requires a complex inter-
play involving myocardial fibers orientated in the longi-
tudinal, oblique and circumferential directions [1–4].
This results in a combination of circumferential shorten-
ing, radial wall thickening, and long axis shortening.
Long axis atrio-ventricular plane displacement has been
shown to be a major contributor to left ventricular
pumping in both health and disease [5, 6]. In addition,
through displacement of the atrio-ventricular annulus,
long axis function seems to affect myocardial function in
unique ways - including mediating left ventricular dia-
stolic filling, and in expediting atrial filling from the
great veins [6, 7]. Long axis dysfunction appears to be an
early marker for a number of pathological states [8].
Moreover, assessment of longitudinal function using
echocardiography has been shown to provide independ-
ent prognostic information in a wide variety of cardiac
conditions [9, 10]. Despite these important and unique
features, long axis function is not routinely assessed or
reported during clinical Cardiovascular Magnetic Reson-
ance (CMR) [11].
We hypothesized that mitral annular plane systolic excur-
sion (MAPSE) measured during cine-CMR imaging reflects
changes in long axis function and may be an early marker
for adverse cardiovascular outcomes. The aims of this study
were therefore: 1) To assess the feasibility and reproducibil-
ity of MAPSE measurements during routine cine-CMR;
and 2) To assess whether MAPSE, as a surrogate for long
axis function, is a predictor of major adverse cardiovascular
events (MACE).
Methods
Study population
Four hundred consecutive outpatients referred for clinical
CMR were prospectively enrolled at a single academic
medical center. Patients were excluded if they had metallic
implants incompatible with CMR, glomerular filtration
rate < 30 ml/min, severe claustrophobia, or mitral valve re-
placement. Information on baseline demographic variables
and prior laboratory testing was obtained from patient
interviews and the electronic medical record. Patients gave
informed written consent for the protocol, which was
approved by the local institutional review board.
CMR acquisition
Images were acquired on a 3 T scanner (Philips Achieva,
Philips Medical Systems, Best, the Netherlands) using a six-
element phased-array receiver coil. Steady-state free-
precession cine images were acquired in multiple short-axis
and three long-axis views (repetition time, 3.0 ms; echo
time, 1.5 ms; flip angle, 40°; slice thickness 6 mm). Short-
axis views were obtained every 1 cm to cover the entire left
ventricle. Gadolinium contrast (0.15 mmol/kg gadoteridol,
Bracco Diagnostics) was administered and delayed enhance-
ment CMR (DE-CMR) was performed 10-15 min later with
a 2D segmented gradient echo phase-sensitive inversion-
recovery sequence in the same views used for cine-CMR.
Inversion delay times were typically 280 to 360 ms
CMR analysis and MAPSE assessment
Septal and lateral mitral annular positions were marked at
end-diastole in the 4-chamber view (Fig. 1). The images
were advanced frame-by-frame to end-systole (just before
mitral valve opening) where septal and lateral mitral annu-
lar positions were again identified. Septal MAPSE was
defined as the distance between the septal mitral annular
position at end-diastole to the septal mitral annular
position at end-systole. Lateral MAPSE was defined as the
distance between the lateral mitral annular position at end-
diastole to the lateral mitral annular position at end-systole
(Fig. 1). Thus MAPSE was measured as the simple linear
displacement between end-diastole and end-systole.
Measurements were manually performed by a CMR phys-
ician who was blinded to patient information and out-
comes. In 50 randomly selected patients, a second blinded
Fig. 1 Measurement of MAPSE. Septal and lateral mitral annular positions were recorded at end diastole (left panel, purple line) and end systole
(right panel, blue line), allowing for assessment of lateral (right panel, red line) and septal MAPSE (right panel, orange line)
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CMR physician measured MAPSE for assessment of inter-
observer variability. In another 50 randomly selected
patients, the same physician re-measured MAPSE in a
blinded fashion for assessment of intra-observer variability.
The presence and location of LGE was determined by
visual inspection using the AHA 17-segment model.
Regional enhancement was scored according to the visual
spatial extent of enhanced tissue within each segment (0
= no enhancement; 1 = 1–25 % enhanced; 2 = 26–
50 %; 3 = 51–75 %; and 4 = 76–100 %) as described
previously [12–16]. The analyses were performed
using WebPAX (Heart IT, Durham, North Carolina).
Follow-up
Patients were followed for the combined primary outcome
of major adverse cardiac events (MACE) - death, non-fatal
myocardial infarction, hospitalization for heart failure or
unstable angina, and late revascularization (>90 days after
CMR). Two cardiologists blinded to CMR results
performed all standardized follow-up procedures. Clinical
follow-up was obtained by review of the electronic
medical records. In cases where records were not found in
the medical chart, treating physicians and patients were
contacted using a standardized questionnaire. Non-fatal
myocardial infarction was defined by the presentation of
an acute coronary syndrome and elevation of cardiac bio-
markers (>99th percentile of the upper limit of normal),
temporally consistent with an acute injury. The definition
of heart failure hospitalization required the presence of an
elevated B-natriuretic peptide (BNP) level in addition to
signs and symptoms of heart failure. Unstable angina was
defined by hospitalization for chest pain plus either coron-
ary angiography revealing stenosis of >70 % or ischemia
on noninvasive stress imaging performed during the
hospitalization. The Social Security Death Index was used
to confirm all cases of death. Time to event was calculated
as the period between the CMR study and the first occur-
rence of a MACE. Patients who did not experience MACE
were censored at time of last follow-up.
Statistical analysis
Normally distributed data were expressed as mean ± SD.
Continuous variables were compared by the Student’s t-test
or Wilcoxon rank-sum (depending on data normality).
Comparisons of discrete variables were made using the chi-
square test; Fisher’s exact test was used when the assump-
tions of the chi-square test were not met. Inter and intra
observer variability was analyzed using the Bland-Altman
method [17]. Kaplan-Meier methods were used to evaluate
time to the primary outcome of MACE. Cox proportional
hazards regression modeling was used to identify factors
that were independently associated with MACE. For the
multivariable model, established clinical risk factors which
were univariate predictors (at p ≤ 0.10) were considered as
candidate variables. To assess the added prognostic value of
lateral MAPSE, the final model was compared with a model
in which lateral MAPSE was not included. The global chi-
square statistic was calculated for both models, and com-
pared using the likelihood ratio test. Model discrimination
was compared by calculating the integrated discrimination
improvement (IDI), which measures the improvement in
sensitivity and specificity of the model with addition of the
new predictor (lateral MAPSE) [18, 19]. Formal risk reclas-
sification analyses were conducted by examining net reclas-
sification improvement (NRI) using categories of <10 %,
10–15 %, and >15 %/year MACE rates to define low, inter-
mediate, and high-risk categories, respectively [18]. A p
value of <0.05 was considered statistically significant.
Results
Patient characteristics
Table 1 summarizes baseline patient characteristics. The
mean age of the study population was 58 ± 15 years.
Forty-five percent of patients were male and 33 % had
diabetes mellitus. Thirty-one percent had known coron-
ary artery disease, and 18 % were current smokers.
Thirty-one percent had a history of heart failure and the
mean ejection fraction was 59 ± 14 %.
Median MAPSE for the population was 1.11 cm. There
was a significantly higher percentage of smokers, diabetics
and patients with prior MI or known CAD in those indi-
viduals with MAPSE <median. Moreover, LVEF was sig-
nificantly higher in patients with MAPSE ≥median.
Inter and intra observer variability
Bland-Altman analysis of interobserver repeatability for
lateral MAPSE showed a bias of −0.01 cm. Limits of
agreement were −0.17 to 0.15 cm. The Bland-Altman
plot showed no systematic bias (Fig. 2a). Bland-Altman
analysis of intraobserver repeatability for lateral MAPSE
showed a bias of −0.002 cm. Limits of agreement were
−0.17 to 0.17 cm. The Bland-Altman plot showed no
systematic bias (Fig. 2b).
Primary outcomes
A total of 72 major adverse cardiac events (MACE)
occurred during a median follow-up of 14.5 months. This
was comprised of 11 deaths, 10 non-fatal myocardial in-
farctions, 12 hospitalizations for heart failure, 28 hospitali-
zations for unstable angina, and 11 late revascularizations.
Outcomes stratified by MAPSE
Overall, patients with lateral MAPSE <median had twice
the number of cumulative MACE when compared to those
with lateral MAPSE ≥median (24 % vs 12 %, p = 0.0018).
By Kaplan-Meier analysis, patients with lateral MAPSE <
median experienced significantly higher incidence of
MACE than patients with lateral MAPSE ≥median (log-
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rank p = 0.027) (Fig. 3). Figure 4 shows the cumulative inci-
dence of MACE stratified by MAPSE and LVEF. MACE
occurred significantly more frequently in individuals with
MAPSE <median, irrespective of LVEF. The highest cu-
mulative incidence of MACE occurred in those with
MAPSE <median and LVEF < 55 %. By univariable ana-
lysis, age, diabetes, hypertension, NYHA class, LV mass
and lateral MAPSE were associated with occurrence of
MACE (at p ≤ 0.10) (Table 2).
Multivariable Analysis and Incremental Prognostic Value
After adjustment for established clinical risk factors
which were univariate predictors (age, diabetes, hyper-
tension, NYHA class, LV mass), lateral MAPSE
remained a significant independent predictor of MACE
(HR = 4.384 per cm decrease; p = 0.020) (Table 2).
Addition of lateral MAPSE to this model resulted in a
significant increase in global chi-square as assessed by
the likelihood ratio test (p = 0.03) and an integrated dis-
crimination improvement of 0.01 (p = 0.01).
Overall, the net reclassification improvement (NRI)
was 0.18 (p = 0.006) across risk categories of MACE. As
shown in Fig. 5, risk reclassification by lateral MAPSE
was most effective in patients at intermediate pre-test
risk, with reclassification of 24 % (27/114) of patients to
low risk and 29 % (33/114) of patients to high risk, with
a low (6.1 %) and high (27.8 %) annual rate of MACE,
respectively. For patients at high pretest risk, lateral
MAPSE reclassified 19 % (35/185) and 5 % (9/185) into
moderate and low risk, with low annual rates of MACE
Table 1 Baseline Characteristics Stratified by Median Level of MAPSE
Characteristics Total Lateral
MAPSE <median
Lateral
MAPSE≥median
P Value
N = 400 N = 195 N = 205
Age (±SD) 57.9 (±14.7) 59.7 (±14.6) 56.2 (±14.6) 0.017
Male % 44.8 47.7 42.0 0.248
BMI (±SD) 30.6 (±6.4) 31.0 (±6.5) 31.1 (±6.3) 0.876
Diabetes % 32.5 38.5 26.8 0.013
Hyperlipidemia % 52.0 56.9 47.3 0.055
Smoking % 18.0 23.6 12.7 0.005
Hypertension % 73.8 76.4 71.2 0.238
Known CAD % 31.1 36.6 25.9 0.020
Prior MI % 13.3 16.4 10.2 0.069
Prior PCI % 15.8 19.5 12.2 0.045
Prior CABG % 3.8 3.1 4.4 0.490
NYHA class 0.6 (±0.9) 0.5 (±0.9) 0.6 (±1.0) 0.295
Heart Failure %
None 69.2 70.7 67.8 0.543
NYHA 1 12.1 12.6 11.6 0.760
NYHA 2 12.3 11.5 13.1 0.642
NYHA 3 5.4 4.7 6.0 0.564
NYHA 4 0.5 0.5 0.5 0.977
Antiplatelet Drug % 53.3 52.5 54.1 0.788
Statin % 50.1 49.6 52.1 0.684
ACE inhibitor % 40.4 43.9 40.0 0.235
Beta Blocker % 64.2 64.7 63.7 0.853
Diuretic % 46.5 42.0 50.7 0.144
LVEF (±SD) 58.9 (±13.7) 55.5 (±15.6) 62.2 (±10.7) <0.001
LV mass g (±SD) 118.8 (±43.3) 123.6 (±48.1) 114.6 (±38.3) 0.039
LGE present % 20.9 26.7 15.3 0.006
ACE angiotensin converting enzyme, BMI body mass index, CABG coronary artery bypass grafting, CAD coronary artery disease, LGE late gadolinium enhancement,
LVEF left ventricular ejection fraction, MAPSE Mitral Annular Plane Systolic Excursion, MI myocardial infarction, NYHA class New York Heart Association Class (class 0
signifies no heart failure), PCI percutaneous coronary intervention, SD standard deviation
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(9.1 and 9.5 %, respectively), which were in contrast to
the high annual rates of MACE (22.3 %) among patients
who remained at high post-test risk.
Discussion
In this study we have shown the feasibility of rapidly asses-
sing MAPSE - as a surrogate of LV long axis function -
during routine cine-CMR. We have also demonstrated
that lateral MAPSE, is an independent predictor of major
adverse cardiovascular events. To our knowledge this is
the first demonstration of the prognostic value of asses-
sing LV long axis function using universally obtained
CMR images and without the need for propriety software.
Long axis function in health and disease
Long axis function plays a fundamental role in cardiac
mechanics: 1) It contributes to ventricular ejection by
reducing long axis LV cavity size as the mitral annulus is
pulled towards the apex [6, 7]. 2) During early diastole,
the potential energy stored during systole creates ven-
tricular suction, critical in facilitating rapid ventricular
filling at low pressures in the normal heart [7, 20]. As
the mitral annulus springs back to its equilibrium pos-
ition it moves around the column of blood passing
through the mitral valve, thus aiding ventricular filling.
Through this simple mechanism, blood that was in the
left atrium finds itself in the ventricle despite remaining
stationary with respect to the apex and chest wall [7]. 3)
Fig. 2 Bland-Altman analysis of lateral MAPSE for a interobserver and b intraobserver variability. Solid line represents the bias. Dashed line
represents the limits of agreement
Fig. 3 Kaplan-Meier curves for MACE, in patients with lateral MAPSE above and below the median. The number of patients at risk at each time
interval for each group is presented
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The motion of the annulus towards the apex during ven-
tricular systole has the effect of correspondingly increasing
the capacity of the atrium as its floor moves downwards -
thus drawing blood into the atrium from the pulmonary
veins [6, 21]. 4) During atrial systole, atrial emptying and
ventricular filling are further facilitated as the mitral annu-
lus is pulled away from the apex by contraction of atrial
myocardium, which is inserted into it [22].
Thus longitudinal movement of the mitral annulus is a
major component of normal heart function. This has
been highlighted by Carlsson et al, who used CMR to
measure the contribution of longitudinal mitral plane
displacement to overall stroke volume in normal subjects,
elite athletes and patients with dilated cardiomyopathy
[5, 6]. They suggested that although stroke volume
was higher in athletes and lower in patients with
cardiomyopathy, the percentage of stroke volume ex-
plained by longitudinal motion was similar at about 60 %.
Longitudinal annular movement therefore appears to be a
dominant contributor to left ventricular pump function in
adults. Interestingly, longitudinal contribution to stroke
volume in healthy children has been reported to be slightly
Fig. 4 Overall incidence of MACE stratified by lateral MAPSE and LVEF
Table 2 Univariable and multivariable predictors of MACE
Variables Univariable Multivariable
Hazard Ratio
(95 % CI)
P Value Hazard Ratio
(95 % CI)
P Value
Age 1.016 (0.999–1.033) 0.0585 0.985 (0.958–1.013) 0.286
Male 1.014 (0.638–1.612) 0.9531 - -
Diabetes 1.693 (1.058–2.713) 0.0309 0.863 (0.428–1.740) 0.680
Hyperlipidemia 1.326 (0.825–2.131) 0.2397 - -
Smoking 0.998 (0.555–1.795) 0.9953 - -
Hypertension 2.482 (1.189–5.181) 0.0066 2.355 (0.820–6.766) 0.112
NYHA class 0.810 (0.618–1.060) 0.1080 0.853 (0.519–1.403) 0.532
LVEF 1.001 (0.985–1.017) 0.9234 - -
LGE present 1.263 (0.757–2.110) 0.3794 - -
LV mass 1.009 (1.002–1.017) 0.0211 1.008 (1.000–1.015) 0.044
Lateral MAPSEa 2.228 (1.051–4.679) 0.0331 4.384 (1.257–15.271) 0.020
Septal MAPSEa 1.585 (0.682–3.715) 0.2865 - -
LGE late gadolinium enhancement, LV left ventricular, LVEF left ventricular ejection fraction, MAPSE Mitral Annular Plane Systolic Excursion, NYHA New York Hear
Association. aper cm decrease
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lower at about 50 % [23]. More recently, Steding-
Ehrenbor and colleagues demonstrated - using CMR - that
the contribution of longitudinal motion to left ventricular
stroke volume remains unchanged during moderate inten-
sity supine exercise [24].
Possibly because of their subendocardial situation, the
more longitudinal fibers are exquisitely sensitive to dis-
turbance by various diseases and pathologies [8]. Mitral
annular motion is rapidly affected by ischemia and there
is a very close interaction between long axis function
and coronary artery disease [4, 8]. Moreover, mitral
annular plane displacement and the corresponding lon-
gitudinal contribution to stroke volume appear also to
be decreased in patients with pulmonary hypertension
compared to controls [25]. Indeed impairment of long
axis function can be present despite preserved overall
LVEF and may provide an early marker of disease. This
may help explain our finding of an independent associ-
ation of MAPSE with adverse cardiovascular events,
independent of LVEF and other risk factors.
MAPSE and global longitudinal strain
Since the cardiac apex is fixed with respect to the chest
wall, changes in long axis function can be assessed by
measuring changes in the position of the atrioventricular
annulus [7]. Indeed, early studies used M-mode echocar-
diography to directly follow the position of the mitral an-
nulus and measure MAPSE [26]. However, M-mode
echocardiographic MAPSE assessment suffers from angle
dependence issues. More recently, tissue doppler of the
mitral annulus and LV strain imaging techniques have
been developed to assess long axis function by echocardi-
ography. Although clinical strain measurements initially
used tissue doppler approaches, these have now been
largely superseded by 2D-speckle tracking methods. Strain
imaging has the potential advantage of providing segmen-
tal and global information regarding longitudinal deform-
ation rather than the monodimensional focal data derived
from MAPSE. However, these strain techniques are highly
dependent on attainment of good quality imaging and
there is lack of standardization between different vendors
[10]. Moreover, analysis can be time consuming and re-
quires significant operator experience [10, 27].
Long axis function and prognosis
MAPSE measured using echocardiography has been
shown to be a predictor of adverse cardiovascular out-
comes in a number of conditions, including atrial fibril-
lation, post-myocardial infarction, heart failure, and
tetralogy of Fallot [28–31]. More recently, there has
been a great deal of interest in the prognostic utility of
echo derived global longitudinal strain, which has been
shown to predict a variety of adverse outcomes in sev-
eral different populations, including acute myocardial
infarction, ischemic cardiomyopathy, heart failure (with
reduced or preserved ejection fraction), aortic stenosis,
Fig. 5 Risk reclassification. Illustration of risk reclassification by addition of lateral MAPSE to a model containing ejection fraction, age, diabetes,
hypertension, NYHA class and LV mass. The upper horizontal bar graph represents the distribution of risk across categories of MACE as estimated
by the model prior to adding lateral MAPSE. The pie graphs represent the proportions of patients in each pre-lateral MAPSE category reassigned
to each risk category after the addition of lateral MAPSE to the risk model. The vertical bar charts at the bottom represent the annualized rates of
MACE in each of the post-lateral MAPSE risk categories
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tetralogy of Fallot, amyloidosis, post heart transplant-
ation, and post anthracycline therapy [10, 28, 32–38].
Echo global longitudinal strain also appears to independ-
ently predict incident atrial fibrillation in a community
based cohort [39].
In this study we did not examine the relationships be-
tween MAPSE and echo derived global longitudinal strain.
However, Riffel et al recently showed that displacement of
the mitral annulus with respect to the cardiac apex - mea-
sured with CMR - correlates well with echo derived global
longitudinal strain but did not provide outcome data [40].
We have now demonstrated for the first time that a sim-
ple, rapid measurement of lateral MAPSE from 4-
chamber cine images, is independently associated with
adverse outcomes in a consecutive series of patients
undergoing CMR. 4-chamber cine-CMR image are
obtained routinely in all CMR protocols. Moreover, the
method is vendor independent and requires no special
analysis software. It can be performed rapidly and shows
good inter and intra observer variability.
Using CMR, Korosoglou et al have shown that strain
encoded magnetic resonance imaging (SENC) provided
additive prognostic information in patients undergoing
dobutamine stress CMR [41]. More recently, Buss and
colleagues demonstrated that LV longitudinal strain
assessed with specialized CMR feature tracking software is
an independent predictor of survival in dilated cardiomyop-
athy [42]. However, to date CMR analysis of strain has
required the use of specialized software. Consequently these
techniques have not achieved widespread clinical use.
Limitations
This is a single-center, observational study and carries all
of the inherent limitations of that study design. As such, it
is likely that some amount of residual confounding re-
mains, despite adjustment for a wide array of clinically
relevant covariates. Patients were clinically referred for
CMR at a single academic medical center and the results
are not necessarily generalizable to the larger population
of patients seen in the community. Our analysis used a
composite of clinical end points with relatively few “hard
end points”, highlighting the need for replication of these
results in a larger cohort with longer follow-up. Indeed,
the lack of univariable association between LGE and
MACE in our population may relate to the above factors.
This highlights the need for replication of these results in
a larger multi-center cohort with longer follow-up allow-
ing for analysis of hard endpoints focusing on specific
populations such as those with known CAD.
In this study we prospectively chose to look only at
lateral and septal MAPSE because these are the two
measurements that have been recommended and histor-
ically performed in the echocardiographic literature [9].
In order to avoid multiple post-hoc statistical comparisons
we chose to limit the number of variables tested to those
that were prospectively selected based on the prior litera-
ture. However, given our results it would be interesting for
future studies to examine the relative prognostic signifi-
cance of anterior and inferior MAPSE.
In contrast to lateral MAPSE, septal MAPSE was not as-
sociated with adverse events in this study. The reason for
this is not clear, although it is well appreciated from echo-
cardiography that parameters of lateral and medial move-
ment of the mitral annulus such as tissue doppler and
MAPSE are significantly different [9, 43]. One possibility
is that perhaps septal MAPSE is more affected by right
ventricular interactions than lateral MAPSE and hence
provides a less direct assessment of LV longitudinal func-
tion. Our MAPSE measurements did not account for pos-
sible translational movements of the mitral annulus which
maybe confounding our assessment of long axis function.
In the echo literature MAPSE measurements have usually
been reported as absolute numbers (not indexed to body/
heart size) based on simple M-mode recordings in the
apical 4-chamber view. For this initial study we wanted to
examine the CMR utility of this very simple measurement
that has been used previously in the echo literature. How-
ever, possible refinements such as normalization to body
size or measurement of apex-to-annulus length would be
interesting to explore in future studies. Nevertheless our
simple, rapid method for assessing long axis function was
independently associated with MACE in this study.
Plasma BNP levels were not measured at the time of the
scanning and hence could not be included in our predict-
ive models. Future studies need to replicate these results
in a larger cohort with longer follow-up and looking at
“hard endpoints” before routine clinical measurement of
lateral MAPSE by CMR can be advocated.
Conclusions
Reduced long axis function assessed with lateral MAPSE
during routine cine-CMR is an independent predictor of
MACE.
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